التفاصيل البيبلوغرافية
| العنوان: |
Bronchodilator responsiveness testing with inhaled budesonide/formoterol in asthma. |
| المؤلفون: |
Nannini, Luis J.1,2 (AUTHOR) ljnannini@hotmail.com, Brandan, N.1 (AUTHOR), Fernández, O. M.1 (AUTHOR) |
| المصدر: |
Journal of Asthma. Nov2023, Vol. 60 Issue 11, p1997-2001. 5p. |
| مصطلحات موضوعية: |
*FORMOTEROL, *BUDESONIDE, *ALBUTEROL, *ASTHMA, *DATABASES |
| مصطلحات جغرافية: |
ARGENTINA |
| مستخلص: |
The choice of bronchodilators for responsiveness testing (BRT) is a clinical decision according to ATS/ERS. Since January 2019 we use budesonide/formoterol for BRT in asthma at our center in Argentina. The aim was to compare budesonide/formoterol with salbutamol for BRT in stable asthmatic patients that were followed up in a short-acting beta2 agonist (SABA)-free asthma center. From the Hospital database, we found for the same patient at least one BRT using salbutamol 200 µg and another with budesonide/formoterol 320/9 µg. We found similar BRT between salbutamol and budesonide/formoterol in 101 asthmatic individuals (26 males) aged 38.14 ± 16.1 yrs (mean ± Standard deviation). The absolute response was 0.18 ± 0.21 L in FEV1 after salbutamol and 0.20 ± 0.22 L in FEV1 after budesonide/formoterol. Afterwards, we showed 202 patients tested with budesonide/formoterol; the mean absolute response was 0.21 ± 0.22 L in FEV1. There were no unexpected safety findings. In asthmatic patients, we demonstrated similar efficacy between Budesonide/formoterol and salbutamol for BRT. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
